Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Nov 13, 2022 2:34pm
282 Views
Post# 35095118

RE:RE:Crutial 450 day data.

RE:RE:Crutial 450 day data.


Can't speak to all you are asking.

The very first 1b patients treated properly were CR for 2 of the 3 patients. They have been followed for years after that one treatment and stayed CR. The competitor, immunotherapy, is often like whack a mole. Hoping that the immune system willl attack the cancer cells and kill enough that there are no survivors. Given enough time if any cells still persist then the cancer comes back. That is why many of the response curves for teh competitors keep showing patients relapsing even if you go way out in time. TLD-1433 causes almost immediate cell death followed by immune reaction against any others. It seems like that if you get to 360 days with no recurrence then you are cured fully. So far. So CR is not for sure 100% but CR maintained to 360 days seems to be a full cure.
 

<< Previous
Bullboard Posts
Next >>